Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New MCO-170AIC CO2 incubator from Panasonic demonstrates exceptional control and optimises cell culture productivity

Published: Monday, June 09, 2014
Last Updated: Monday, June 09, 2014
Bookmark and Share
New MCO-170AIC CO2 incubators from Panasonic deliver outstanding quality in performance, maximise cell culture efficiency and provide optimum results and reproducibility. Designed specifically for the safe, consistent cultivation of successful cell lines, this latest innovation offers the very highest levels of precision, security and ease of use.

New MCO-170AIC CO2 incubators from Panasonic deliver outstanding quality in performance, maximise cell culture efficiency and provide optimum results and reproducibility. Designed specifically for the safe, consistent cultivation of successful cell lines, this latest innovation offers the very highest levels of precision, security and ease of use.

The MCO-170AIC CO2 incubators are designed with ease of use and work efficiency in mind. Integrated shelf supports provide space for more culture vessels and an easy to clean incubator interior. A new full colour LCD touch screen gives clear information of incubator status (chamber temperature, CO2 level, door open status and alarms) with easy access to controller functions for fast, convenient set-up. A graphical chart display allows users to quickly review incubator performance and a new USB port allows laboratories to optimise cell culture protocols and adhere to standard operating procedures by conveniently transferring logged data to a USB stick.

The Panasonic MCO-170AIC CO2 incubators benefit from a Direct heat and air jacket system for high precision temperature control and rapid recovery, ensuring cultures are always maintained under optimum conditions. A dual IR CO2 sensor maintains accurate control of critical CO2 levels by minimising the effect of temperature and humidity changes during door opening for outstanding performance and fast recovery. A precise culture environment is further ensured by advanced PID control of CO2 and temperature. Enhanced insulation performance and lower energy consumption means users can achieve improved culture conditions, along with a reduction in electrical running costs.1

To provide optimum protection for valuable cultures, MCO-170AIC CO2 incubators incorporate continuous background contamination control with Panasonic’s InCu saFe® copper-enriched stainless steel interior and optional Safe Cell® UV technology, with new increased UV lamp life, which sterilises airborne and water pan contaminants. Furthermore, the optional H2O2 vapour sterilisation cycle provides a complete, validatable decontamination with a downtime of less than 3 hours. For enhanced security, the incubators are also offered with a new optional electric door lock with password.

The MCO-170AIC CO2 incubator delivers a precisely controlled environment and optimum protection for sensitive cell cultures and increased work efficiency.

 1) Compared to previous Panasonic 170 litre CO2 incubators


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
First Made-in-Singapore Cancer Drug Enters Clinical Testing
The drug prevents cancer progression and paves the way for new advancements in cancer therapeutics.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!